Login / Signup

Early tumor shrinkage is independently associated with improved overall survival among patients with metastatic renal cell carcinoma: a validation study using the COMPARZ cohort.

Viktor GruenwaldMarion DietrichGregory R Pond
Published in: World journal of urology (2018)
Similar results were found for eTS at the 42 and 90 days landmarks. eTS ≥ 10% has prognostic relevance in mRCC and reflects a putative tool to guide future clinical treatment.
Keyphrases
  • metastatic renal cell carcinoma
  • transcription factor
  • current status
  • clinical evaluation